FY2025 · ended Dec 31, 2025 · Revenue $299,061 · Filed Jun 5, 2026
TAO Synergies Inc. (TAOX) files with the SEC under industry code 6199, Finance Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $299,061 and a net loss of $28.7 million.
Revenue (TTM)
$772,499
Net income (TTM)
$-16.65M
+41.4% vs year-ago TTM
Operating cash flow (TTM)
$-6.20M
-25.4% vs year-ago TTM
Free cash flow
$-5.18M
+53.9% vs prior year
EPS (TTM)
$-3.41
+83.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
7.47M
+437.6% vs prior year
Net cash
—
Operating margin
-1013.5%
FY 2026
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- TAOX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1571934
- Former names
- Synaptogenix, Inc. (until Jun 24, 2025); NEUROTROPE BIOSCIENCE, INC. (until Nov 20, 2020)
Other Finance Services companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $299,061 | — | — | — | — |
| Operating income | -$9.0M | — | — | — | — |
| Net income | -$28.7M | -$12.8M | -$6.0M | -$5.6M | -$12.6M |
| Diluted EPS | -$8.81 | -$10.99 | $29.56 | -$0.81 | $2.51 |
| Operating cash flow | -$6.4M | -$4.9M | -$5.2M | -$11.2M | -$8.7M |
| Free cash flow | — | — | -$5.2M | -$11.2M | -$8.7M |
| Total assets | $25.8M | $17.7M | $31.1M | $38.6M | $35.5M |
| Total liabilities | $3.9M | $11.0M | $5.5M | $3.2M | — |
| Stockholders' equity | $21.1M | $5.9M | $24.3M | $32.7M | $33.5M |
| Cash and investments | $5.5M | $17.7M | $30.1M | $37.5M | $34.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-K/A | Amended annual report | Jun 5, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 19, 2025 | Dec 18, 2025 |
| ARS | Annual report to shareholders | Nov 17, 2025 | Dec 31, 2024 |
All 243 TAO Synergies Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.